$93.7 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 12 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CDLX | Cardlytics, Inc. | $27,645,000 | -56.7% | 2,552,626 | 0.0% | 29.51% | -7.8% | |
FATE | Sell | Fate Therapeutics, Inc. | $23,391,000 | -41.9% | 1,823,186 | -26.3% | 24.97% | +23.8% |
STIM | Neuronetics, Inc. | $15,959,000 | -39.6% | 824,765 | 0.0% | 17.04% | +28.7% | |
KALA | Kala Pharmaceuticals, Inc. | $9,084,000 | -50.5% | 1,857,582 | 0.0% | 9.70% | +5.6% | |
TTOO | T2 Biosystems, Inc. | $5,544,000 | -59.6% | 1,841,924 | 0.0% | 5.92% | -13.9% | |
ASNS | Arsanis, Inc. | $4,336,000 | +43.2% | 1,868,957 | 0.0% | 4.63% | +205.3% | |
SELB | Selecta Biosciences, Inc. | $4,274,000 | -82.9% | 1,606,813 | 0.0% | 4.56% | -63.5% | |
LIFE | Atyr Pharma Inc. | $906,000 | -39.0% | 1,827,992 | 0.0% | 0.97% | +30.1% | |
TRVN | Trevena, Inc. | $883,000 | -79.7% | 2,053,540 | 0.0% | 0.94% | -56.7% | |
PULM | Pulmatrix, Inc. | $863,000 | -35.1% | 3,594,381 | 0.0% | 0.92% | +38.3% | |
GNCA | Genocea Biosciences, Inc. | $565,000 | -63.2% | 1,968,606 | 0.0% | 0.60% | -21.5% | |
DARE | Dare Bioscience, Inc. | $232,000 | -27.0% | 326,243 | 0.0% | 0.25% | +56.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Fate Therapeutics, Inc. | 30 | Q2 2021 | 79.2% |
Atyr Pharma Inc. | 26 | Q3 2021 | 15.1% |
Trevena, Inc. | 22 | Q2 2019 | 24.9% |
Genocea Biosciences, Inc. | 21 | Q1 2019 | 32.5% |
Selecta Biosciences, Inc. | 20 | Q1 2021 | 39.5% |
T2 Biosystems, Inc. | 20 | Q2 2019 | 36.1% |
Dare Bioscience, Inc. | 17 | Q3 2021 | 3.9% |
Pulmatrix, Inc. | 16 | Q1 2019 | 15.4% |
Cerulean Pharma Inc | 13 | Q2 2017 | 16.2% |
Kala Pharmaceuticals, Inc. | 11 | Q1 2020 | 37.1% |
View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
3 | 2022-03-30 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-12 |
13F-HR | 2021-05-12 |
13F-HR | 2021-02-12 |
13F-HR | 2020-11-12 |
13F-HR | 2020-08-12 |
13F-HR | 2020-05-14 |
4 | 2020-05-06 |
3 | 2020-04-30 |
View Polaris Venture Management Co. V, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.